| LVC | Name: | 4-(2-oxopropyl)benzoic acid | Formula: | C10 H10 O3 | SMILES: | O=C(C)Cc1ccc(cc1)C(=O)O | InChi: | InChI=1S/C10H10O3/c1-7(11)6-8-2-4-9(5-3-8)10(12)13/h2-5H,6H2,1H3,(H,12,13) | Definition date: | 2022-03-04 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | 4-(2-oxopropyl)benzoic acid |
|
| LVK | Name: | 4-propanoylbenzoic acid | Formula: | C10 H10 O3 | SMILES: | OC(=O)c1ccc(cc1)C(=O)CC | InChi: | InChI=1S/C10H10O3/c1-2-9(11)7-3-5-8(6-4-7)10(12)13/h3-6H,2H2,1H3,(H,12,13) | Definition date: | 2022-03-04 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | 4-propanoylbenzoic acid |
|
| 4Q8 | Name: | 5-methyl-1-(phenylmethyl)imidazole | Formula: | C11 H12 N2 | SMILES: | Cc1cncn1Cc2ccccc2 | InChi: | InChI=1S/C11H12N2/c1-10-7-12-9-13(10)8-11-5-3-2-4-6-11/h2-7,9H,8H2,1H3 | Definition date: | 2023-01-09 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | 5-methyl-1-(phenylmethyl)imidazole |
|
| F3L | Name: | 4-[(3~{S},4~{S})-4-(aminomethyl)-1-(5-chloranylpyridin-2-yl)sulfonyl-4-oxidanyl-pyrrolidin-3-yl]oxy-2-fluoranyl-benzenecarbonitrile | Formula: | C17 H16 Cl F N4 O4 S | SMILES: | NC[C]1(O)CN(C[CH]1Oc2ccc(C#N)c(F)c2)[S](=O)(=O)c3ccc(Cl)cn3 | InChi: | InChI=1S/C17H16ClFN4O4S/c18-12-2-4-16(22-7-12)28(25,26)23-8-15(17(24,9-21)10-23)27-13-3-1-11(6-20)14(19)5-13/h1-5,7,15,24H,8-10,21H2/t15-,17-/m0/s1 | Synonyms: | 4-[(3S,4S)-4-(aminomethyl)-1-(5-chloropyridin-2-yl)sulfonyl-4-hydroxypyrrolidin-3-yl]oxy-2-fluorobenzonitrile | Definition date: | 2023-06-27 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | 4-[(3~{S},4~{S})-4-(aminomethyl)-1-(5-chloranylpyridin-2-yl)sulfonyl-4-oxidanyl-pyrrolidin-3-yl]oxy-2-fluoranyl-benzenecarbonitrile |
|
| F9M | Name: | [6-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)-1,3-thiazol-2-yl]amino]pyridin-3-yl]-[(1~{S},5~{R})-3-[5-(trifluoromethyl)pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone | Formula: | C25 H23 F3 N8 O S2 | SMILES: | Cc1sc(c(C)n1)c2csc(Nc3ccc(cn3)C(=O)N4[CH]5CC[CH]4CN(C5)c6ncc(cn6)C(F)(F)F)n2 | InChi: | InChI=1S/C25H23F3N8OS2/c1-13-21(39-14(2)32-13)19-12-38-24(33-19)34-20-6-3-15(7-29-20)22(37)36-17-4-5-18(36)11-35(10-17)23-30-8-16(9-31-23)25(26,27)28/h3,6-9,12,17-18H,4-5,10-11H2,1-2H3,(H,29,33,34)/t17-,18+ | Definition date: | 2023-07-04 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | [6-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)-1,3-thiazol-2-yl]amino]pyridin-3-yl]-[(1~{S},5~{R})-3-[5-(trifluoromethyl)pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone |
|
| A1AJQ | Name: | 4-(piperazin-1-yl)quinoline | Formula: | C13 H15 N3 | SMILES: | c1cc(c2ccccc2n1)N1CCNCC1 | InChi: | InChI=1S/C13H15N3/c1-2-4-12-11(3-1)13(5-6-15-12)16-9-7-14-8-10-16/h1-6,14H,7-10H2 | Definition date: | 2024-04-03 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | 4-(piperazin-1-yl)quinoline |
|
| A1AJR | Name: | 1,2,3,4-tetrahydro-1,5-naphthyridine | Formula: | C8 H10 N2 | SMILES: | c1ccnc2CCCNc12 | InChi: | InChI=1S/C8H10N2/c1-3-7-8(9-5-1)4-2-6-10-7/h1,3,5,10H,2,4,6H2 | Definition date: | 2024-04-03 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | 1,2,3,4-tetrahydro-1,5-naphthyridine |
|
| A1AJV | Name: | 3-ethenyl-1,2-dimethyl-pyrazole | Formula: | C7 H11 N2 | SMILES: | C[n+]1ccc(C=C)n1C | InChi: | InChI=1S/C7H11N2/c1-4-7-5-6-8(2)9(7)3/h4-6H,1H2,2-3H3/q+1 | Definition date: | 2024-04-03 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | 5-ethenyl-1,2-dimethyl-1H-pyrazol-2-ium |
|
| A1AJY | Name: | 3-ethenyl-1-methyl-pyridine | Formula: | C8 H10 N | SMILES: | C[n+]1cccc(C=C)c1 | InChi: | InChI=1S/C8H10N/c1-3-8-5-4-6-9(2)7-8/h3-7H,1H2,2H3/q+1 | Definition date: | 2024-04-03 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | 3-ethenyl-1-methylpyridin-1-ium |
|
| A1AJZ | Name: | 4-(2-hydroxyethyl)-5-methyl-1,2-dihydro-3H-pyrazol-3-one | Formula: | C6 H10 N2 O2 | SMILES: | OCCC=1C(=O)NNC=1C | InChi: | InChI=1S/C6H10N2O2/c1-4-5(2-3-9)6(10)8-7-4/h9H,2-3H2,1H3,(H2,7,8,10) | Definition date: | 2024-04-03 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | 4-(2-hydroxyethyl)-5-methyl-1,2-dihydro-3H-pyrazol-3-one |
|
| A1AKA | Name: | (8S)-3-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine | Formula: | C7 H11 N3 | SMILES: | Cc1cnn2CCNCc12 | InChi: | InChI=1S/C7H11N3/c1-6-4-9-10-3-2-8-5-7(6)10/h4,8H,2-3,5H2,1H3 | Definition date: | 2024-04-03 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | (8S)-3-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine |
|
| A1AKB | Name: | N,N-dimethylpiperazine-1-carboxamide | Formula: | C7 H15 N3 O | SMILES: | O=C(N(C)C)N1CCNCC1 | InChi: | InChI=1S/C7H15N3O/c1-9(2)7(11)10-5-3-8-4-6-10/h8H,3-6H2,1-2H3 | Definition date: | 2024-04-03 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | N,N-dimethylpiperazine-1-carboxamide |
|
| A1AOE | Name: | (2R)-1-(4-aminopiperidin-1-yl)-3-[3-(trifluoromethyl)phenoxy]propan-2-ol | Formula: | C15 H21 F3 N2 O2 | SMILES: | OC(CN1CCC(N)CC1)COc1cc(ccc1)C(F)(F)F | InChi: | InChI=1S/C15H21F3N2O2/c16-15(17,18)11-2-1-3-14(8-11)22-10-13(21)9-20-6-4-12(19)5-7-20/h1-3,8,12-13,21H,4-7,9-10,19H2/t13-/m1/s1 | Definition date: | 2024-04-19 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | (2R)-1-(4-aminopiperidin-1-yl)-3-[3-(trifluoromethyl)phenoxy]propan-2-ol |
|
| A1AOF | Name: | (2S)-1-{[(1R,5R)-3-azabicyclo[3.1.0]hexan-6-yl]amino}-3-(3,5-dichlorophenoxy)propan-2-ol | Formula: | C14 H18 Cl2 N2 O2 | SMILES: | Clc1cc(cc(Cl)c1)OCC(O)CNC1C2CNCC21 | InChi: | InChI=1S/C14H18Cl2N2O2/c15-8-1-9(16)3-11(2-8)20-7-10(19)4-18-14-12-5-17-6-13(12)14/h1-3,10,12-14,17-19H,4-7H2/t10-,12-,13-/m0/s1 | Definition date: | 2024-04-19 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | (2S)-1-{[(1R,5R)-3-azabicyclo[3.1.0]hexan-6-yl]amino}-3-(3,5-dichlorophenoxy)propan-2-ol |
|
| A1AON | Name: | (2S)-1-(3,4-dichlorophenoxy)-3-(4-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}piperidin-1-yl)propan-2-ol | Formula: | C19 H21 Cl2 F3 N4 O2 | SMILES: | OC(CN1CCC(CC1)Nc1nc(ccn1)C(F)(F)F)COc1ccc(Cl)c(Cl)c1 | InChi: | InChI=1S/C19H21Cl2F3N4O2/c20-15-2-1-14(9-16(15)21)30-11-13(29)10-28-7-4-12(5-8-28)26-18-25-6-3-17(27-18)19(22,23)24/h1-3,6,9,12-13,29H,4-5,7-8,10-11H2,(H,25,26,27)/t13-/m0/s1 | Definition date: | 2024-04-19 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | (2S)-1-(3,4-dichlorophenoxy)-3-(4-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}piperidin-1-yl)propan-2-ol |
|
| FDO | Name: | (2~{R})-4-methyl-2-(methylamino)pentanamide | Formula: | C7 H16 N2 O | SMILES: | CN[CH](CC(C)C)C(N)=O | InChi: | InChI=1S/C7H16N2O/c1-5(2)4-6(9-3)7(8)10/h5-6,9H,4H2,1-3H3,(H2,8,10)/t6-/m1/s1 | Definition date: | 2023-07-19 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | (2~{R})-4-methyl-2-(methylamino)pentanamide |
|
| A1ACD | Name: | 1-{2-deoxy-5-O-[(R)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]methyl}phosphoryl]-beta-D-threo-pentofuranosyl}-5-methylpyrimidine-2,4(1H,3H)-dione | Formula: | C11 H19 N2 O13 P3 | SMILES: | O=P(O)(O)OP(=O)(O)CP(=O)(O)OCC1OC(CC1O)N1C=C(C)C(=O)NC1=O | InChi: | InChI=1S/C11H19N2O13P3/c1-6-3-13(11(16)12-10(6)15)9-2-7(14)8(25-9)4-24-27(17,18)5-28(19,20)26-29(21,22)23/h3,7-9,14H,2,4-5H2,1H3,(H,17,18)(H,19,20)(H,12,15,16)(H2,21,22,23)/t7-,8-,9-/m1/s1 | Definition date: | 2024-01-10 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | 1-{2-deoxy-5-O-[(R)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]methyl}phosphoryl]-beta-D-threo-pentofuranosyl}-5-methylpyrimidine-2,4(1H,3H)-dione |
|
| A1AD8 | Name: | (2P,3P,8S)-2-(5-fluoropyridin-2-yl)-6,6-dimethyl-3-(1H-pyrazolo[3,4-b]pyridin-4-yl)-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazine | Formula: | C19 H17 F N6 O | SMILES: | Fc1ccc(nc1)c1nn2CC(C)(C)OCc2c1c1ccnc2[NH]ncc21 | InChi: | InChI=1S/C19H17FN6O/c1-19(2)10-26-15(9-27-19)16(12-5-6-21-18-13(12)8-23-24-18)17(25-26)14-4-3-11(20)7-22-14/h3-8H,9-10H2,1-2H3,(H,21,23,24) | Definition date: | 2024-02-05 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | (2P,3P,8S)-2-(5-fluoropyridin-2-yl)-6,6-dimethyl-3-(1H-pyrazolo[3,4-b]pyridin-4-yl)-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazine |
|
| A1H1O | Name: | (1R,5S,9S,16R,20R,24S,28S,35R)-22-(Dihydroxyphosphoryloxy)tridecacyclo[22.14.1.15,20.19,16.128,35.02,23.04,21.06,19.08,17.010,15.025,38.027,36.029,34]dotetraconta-2(23),3,6,8(17),10,12,14,18,21,25,27(36),29,31,33,37-pentadecaen-3-ol | Formula: | C42 H31 O5 P | SMILES: | Oc1c2[CH]3C[CH](c4cc5[CH]6C[CH](c7ccccc67)c5cc34)c2c(O[P](O)(O)=O)c8[CH]9C[CH](c%10cc%11[CH]%12C[CH](c%13ccccc%12%13)c%11cc9%10)c18 | InChi: | InChI=1S/C42H31O5P/c43-41-37-33-15-35(31-13-27-23-9-21(25(27)11-29(31)33)17-5-1-3-7-19(17)23)39(37)42(47-48(44,45)46)40-36-16-34(38(40)41)30-12-26-22-10-24(28(26)14-32(30)36)20-8-4-2-6-18(20)22/h1-8,11-14,21-24,33-36,43H,9-10,15-16H2,(H2,44,45,46)/t21-,22+,23+,24-,33-,34+,35+,36- | Definition date: | 2024-01-03 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 |
|
| A1H9R | Name: | ~{N}-(cyclobutylmethyl)-1,3-dimethyl-pyrazole-4-carboxamide | Formula: | C11 H17 N3 O | SMILES: | Cn1cc(C(=O)NCC2CCC2)c(C)n1 | InChi: | InChI=1S/C11H17N3O/c1-8-10(7-14(2)13-8)11(15)12-6-9-4-3-5-9/h7,9H,3-6H2,1-2H3,(H,12,15) | Definition date: | 2024-04-29 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | ~{N}-(cyclobutylmethyl)-1,3-dimethyl-pyrazole-4-carboxamide |
|
| A1H9U | Name: | ~{N}-(3-azanyl-2-methyl-phenyl)propanamide | Formula: | C10 H14 N2 O | SMILES: | CCC(=O)Nc1cccc(N)c1C | InChi: | InChI=1S/C10H14N2O/c1-3-10(13)12-9-6-4-5-8(11)7(9)2/h4-6H,3,11H2,1-2H3,(H,12,13) | Synonyms: | N-(3-amino-2-methylphenyl)propanamide | Definition date: | 2024-04-29 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | ~{N}-(3-azanyl-2-methyl-phenyl)propanamide |
|
| A1H9V | Name: | ~{N},~{N}-dimethyl-1~{H}-pyrazole-4-sulfonamide | Formula: | C5 H9 N3 O2 S | SMILES: | CN(C)[S](=O)(=O)c1c[nH]nc1 | InChi: | InChI=1S/C5H9N3O2S/c1-8(2)11(9,10)5-3-6-7-4-5/h3-4H,1-2H3,(H,6,7) | Synonyms: | N,N-dimethyl-1H-pyrazole-4-sulfonamide | Definition date: | 2024-04-29 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | ~{N},~{N}-dimethyl-1~{H}-pyrazole-4-sulfonamide |
|
| A1H9W | Name: | [4-(methylamino)oxan-4-yl]methanol | Formula: | C7 H15 N O2 | SMILES: | CNC1(CO)CCOCC1 | InChi: | InChI=1S/C7H15NO2/c1-8-7(6-9)2-4-10-5-3-7/h8-9H,2-6H2,1H3 | Definition date: | 2024-04-29 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | [4-(methylamino)oxan-4-yl]methanol |
|
| A1H9X | Name: | 5-[(phenylmethyl)amino]-1~{H}-pyrimidine-2,4-dione | Formula: | C11 H11 N3 O2 | SMILES: | O=C1NC=C(NCc2ccccc2)C(=O)N1 | InChi: | InChI=1S/C11H11N3O2/c15-10-9(7-13-11(16)14-10)12-6-8-4-2-1-3-5-8/h1-5,7,12H,6H2,(H2,13,14,15,16) | Synonyms: | 5-(Benzylamino)pyrimidine-2,4(1h,3h)-dione | Definition date: | 2024-04-29 | Last modified: | 2024-05-03 | Release date: | 2024-05-08 | Identifier: | 5-[(phenylmethyl)amino]-1~{H}-pyrimidine-2,4-dione |
|
| 1CC | Name: | 5-carboxy-2'-deoxycytidine monophosphate | Formula: | C10 H14 N3 O9 P | SMILES: | O=C(O)C=1C(=NC(=O)N(C=1)C2OC(C(O)C2)COP(=O)(O)O)N | InChi: | InChI=1S/C10H14N3O9P/c11-8-4(9(15)16)2-13(10(17)12-8)7-1-5(14)6(22-7)3-21-23(18,19)20/h2,5-7,14H,1,3H2,(H,15,16)(H2,11,12,17)(H2,18,19,20)/t5-,6+,7+/m0/s1 | Definition date: | 2011-11-17 | Last modified: | 2024-04-29 | Identifier: | 5-carboxy-2'-deoxycytidine 5'-(dihydrogen phosphate) |
|